← Back
Orthofix Medical
OFIX · listed on Nasdaq · worth $399.38 million
$10.04
+1.99% on Oct 29
Six insider buys in the last year, $4.47 million in all. None in the last two weeks.
Green dot = an insider bought red = sold◆ = company newsA number = that many on nearby days · click a mark to see who, or read the filing
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
40.4M shares
99% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, two insiders bought Orthofix Medical stock and four insiders sold. None of the 8 sales is marked on its filing as planned in advance. The biggest seller was Juniper Investment Company.
How each buyer's earlier purchases went: the stock about six months later, beside the S&P 500 over the same days. Purchases planned in advance are left out. Past results, not a forecast.
10% owner
Juniper Investment Company
Bought $1.68M on Sep 21 — 190,000 shares at $8.86, held through a trust or family, 5.0% of what they now own.
No earlier purchases to measure
10% owner
Engine Capital Management
Bought $1.47M on Feb 24 — 117,076 shares at $12.55, held through a trust or family, 3.2% of what they now own.
1 of 2 earlier purchases did better than the S&P 500
Planned sales
Form 144 notices filed for Orthofix Medical in recent months, beside the Form 4 sales reported after each. A notice says a person intends to sell; it is not a sale.
President Patrick Fisher filed to sell 450 shares on 1 Sep; no sale reported yet10b5-1 plan adopted 29 May 2026 · Notice on SEC.gov
All reports
Every insider trade and SEC report we hold for Orthofix Medical.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Sep 23BoughtJuniper Investment CompanySep 23 · Traded Sep 21 · 10% owner+5.0%via a trust or family190,000 @ $8.86$1.68M
Sep 23BoughtJuniper Investment CompanySep 23 · Traded Sep 18 · 10% owner+3.4%via a trust or family120,000 @ $8.74$1.05M
Sep 22SoldJuniper Investment CompanySep 22 · Traded Sep 21 · 10% ownervia a trust or family190,000 @ $8.86$1.68M
Sep 22SoldJuniper Investment CompanySep 22 · Traded Sep 18 · 10% ownervia a trust or family120,000 @ $8.74$1.05M
14 more with Pro →Analysts, earnings and news
Analysts' price target
$13.00 average
4 analysts
Analysts' opinions, which tend to run optimistic. Not our forecast or advice.
Profit vs what was expected
3 of 4 quarters above
Q2 '26$0.07 a share+$0.10
Q1 '26−$0.11 a share+$0.18
Q4 '25$0.24 a share−$0.18
Q3 '25$0.20 a share+$0.08